Skip to content

Clinical trials

Cerebral Hemorrhage trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebral Hemorrhage Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20143
20171
20181
20201
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center3
Novo Nordisk A/S2
The George Institute2
Insel Gruppe AG, University Hospital Bern1
Leiden University Medical Center1
Maastricht University Medical Center1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebral Hemorrhage11
Cerebral Small Vessel Diseases2
Cognitive Dysfunction2
Hypertension2
Stroke2
Atrial Fibrillation1
Cerebral Amyloid Angiopathy1
Dementia, Vascular1
Hemorrhagic Stroke1
Intracranial Hemorrhage, Hypertensive1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.